The research team, led by Shih-Feng Chen of New Taipei City Hospital and National Taiwan University College of Public Health, together with colleagues including senior author I-Wen Wu of Taipei Medical University Hospital, drew on two of Taiwan’s most comprehensive national data resources: the National Health Insurance Research Database, which captures nearly the entire island’s medical encounters, and the Taiwan Air Quality Monitoring Database maintained by the Ministry of Environment. By linking these repositories, the investigators constructed a cohort of 472,141 adults diagnosed with stage 1 through stage 3a chronic kidney disease between 2012 and 2022, a window of the disease in which intervention still holds genuine promise. Patients were followed through 2023, allowing the researchers to observe who progressed to advanced kidney disease, who began maintenance dialysis, and who died over the ensuing years.

What distinguishes this study from much of the prior literature is its focus on change rather than static exposure. The researchers defined a metric they call delta PM2.5: the difference between each patient’s average PM2.5 concentration over the 365 days before enrollment and the average over the 365 days before the end of follow-up. This design asks a clinically urgent question: if a patient’s air quality improves, or worsens, does their kidney disease trajectory change accordingly? Because Taiwan’s air quality varied considerably across the study decade, driven by shifting emissions from industry, traffic, and transboundary pollution, the cohort naturally contained patients whose exposures fell, rose, or held steady, providing the statistical leverage needed to separate the effect of changing pollution from the effect of living in a persistently polluted place.

The headline numbers are striking. Each 1 microgram per cubic meter reduction in long-term PM2.5 exposure was associated with a 5 percent lower risk of progressing to advanced chronic kidney disease, a 3 percent lower risk of starting dialysis, and a 6 percent lower risk of death from any cause. When the investigators grouped patients into tertiles of exposure change, the pattern became even more vivid. Compared with the middle reference tertile, patients in the group with the greatest improvement in air quality exhibited 34 percent lower risks of advanced progression, 17 percent lower risks of dialysis initiation, and 36 percent lower risks of mortality. At the opposite extreme, patients whose air quality deteriorated the most faced 1.31-fold higher risks of advanced progression and 1.28-fold higher risks of death, with dialysis risk also modestly elevated at 1.02-fold. The analyses were performed using multivariate Cox proportional hazards models, which adjust for a battery of potential confounders including age, sex, comorbidities captured by the Charlson Comorbidity Index, medications, and socioeconomic indicators.

Sensitivity and dose-response analyses reinforced the central finding. Restricted cubic spline modeling, a technique that allows the relationship between exposure and outcome to bend flexibly rather than being forced into a straight line, indicated that the associations were near-linear across the observed range of exposure change. In practical terms, every incremental improvement in air quality appeared to confer additional benefit, with protective effects attenuating only beyond a reduction of roughly 7 micrograms per cubic meter, a threshold that suggests diminishing returns once air quality has improved substantially. Kaplan-Meier survival curves, which track event-free survival over time, showed a significant and dose-dependent separation across the tertile groups, with the trend reaching a P value below 0.001, indicating that the differences were extremely unlikely to be products of chance.

Subgroup analyses added a layer of equity-relevant insight. The protective association of PM2.5 reduction was consistently stronger, or at least more pronounced, in two groups: men and individuals with monthly incomes at or below NT$21,900, a threshold corresponding to Taiwan’s basic living wage. This pattern echoes a recurring theme in environmental health research, namely that populations with fewer resources often face higher baseline exposures, greater occupational and residential proximity to pollution sources, and fewer means of self-protection, such as air filtration at home or the ability to relocate. When air quality improves at the population level, those who bore the brunt of the pollution stand to gain the most. The authors note that public health strategies promoting air quality may therefore represent particularly effective early interventions for populations vulnerable to PM2.5-related kidney injury.

The biological plausibility underlying these associations has been building for years. Fine particulate matter, defined as particles smaller than 2.5 micrometers in diameter, is small enough to penetrate deep into the lungs and cross into the bloodstream, where it triggers systemic inflammation, oxidative stress, and endothelial dysfunction. The kidneys, with their dense network of tiny capillaries, are exquisitely sensitive to these insults. Previous research has linked chronic PM2.5 exposure to albuminuria, accelerated loss of estimated glomerular filtration rate, new-onset kidney disease, and faster progression toward end-stage renal disease. What has been missing, and what this study supplies, is evidence at scale that the damage is not a one-way street: improving exposure appears to slow the machinery of progression even in people whose disease has already been diagnosed. That reversibility is what elevates the finding from epidemiological observation to actionable clinical strategy.

The study’s scale and design carry real weight, but the authors and the data themselves invite careful interpretation. As a retrospective cohort, the analysis links exposure changes to outcomes statistically rather than through randomized assignment, so residual confounding by unmeasured lifestyle factors, changes in residence, or concurrent health interventions cannot be fully excluded. The exposure estimates, drawn from fixed monitoring stations, capture community-level concentrations rather than personal doses, and individual mobility patterns introduce inevitable misclassification. The team addressed death as a competing risk in supplementary analyses and conducted extensive sensitivity testing, but the observational nature of the data means the findings describe strong associations rather than proven causation. Even so, the consistency of the effect across three distinct outcomes, the dose-dependent gradients, and the near-linear spline relationships collectively argue for a genuine biological signal.

For clinicians, the implications are tantalizing. Chronic kidney disease affects roughly one in ten adults worldwide, and early-stage intervention is the only realistic hope of stemming the tide of patients ultimately requiring dialysis or transplantation, therapies of enormous cost and limited availability. Counseling patients about air quality has rarely featured in nephrology guidelines, yet this study suggests it may belong there alongside blood pressure control, glycemic management, and renoprotective medication. For policymakers, the message is even more direct: every microgram per cubic meter of PM2.5 removed from the atmosphere is not just a respiratory or cardiovascular victory but a renal one, potentially deferring dialysis for thousands and saving lives in the process. In a decade when many nations have demonstrated that determined regulation can meaningfully reduce particulate pollution, Taiwan’s half-million-patient record offers a compelling quantification of what those cleaner skies buy in human health, kidney by kidney.

Subject of Research: Association between long-term changes in PM2.5 air pollution exposure and chronic kidney disease progression and mortality in early-stage CKD patients in Taiwan

Article Title: Association of PM2.5 changes with advanced kidney disease progression and mortality in patients with early CKD: a nationwide retrospective cohort study in Taiwan

Article References: Chen, S.-F., Lai, Y.-C., Chien, Y.-H., Hung, K.-C., & Wu, I.-W. (2026). Association of PM2.5 changes with advanced kidney disease progression and mortality in patients with early CKD: a nationwide retrospective cohort study in Taiwan. Environmental Health. https://doi.org/10.1186/s12940-026-01339-y

Image Credits: AI Generated

DOI: 10.1186/s12940-026-01339-y

Keywords: PM2.5, air pollution, chronic kidney disease, CKD progression, dialysis, mortality, Taiwan, retrospective cohort study, nephrology, environmental health, public health, fine particulate matter

Plants are not passive components of the climate system. Forests, grasslands, crops, and other vegetation release biogenic volatile organic compounds, or BVOCs, into the atmosphere. Among the most important are isoprene and monoterpenes, highly reactive gases that can interact with sunlight, nitrogen oxides, and other atmospheric chemicals. These reactions can produce ozone near the ground and contribute to biogenic secondary organic aerosols, microscopic particles that can penetrate deep into the lungs.

The researchers were particularly concerned that many atmospheric chemistry models still use vegetation information from 2003 to estimate these natural emissions. East Asia has undergone major ecological changes since then, driven by warming temperatures, altered rainfall, land-use change, urban expansion, forest development, and shifting agricultural patterns. When the vegetation map does not reflect current conditions, the emissions calculated by the model may also be out of date, potentially distorting forecasts of air pollution and assessments of climate-related environmental risk.

To test the effect, the team used the WRF-Chem atmospheric chemistry model together with the MEGAN biogenic emissions model. They replaced the default 2003 vegetation dataset with satellite-derived observations from 2024, while keeping the model configuration and meteorological conditions consistent. This design allowed the scientists to isolate the influence of vegetation change itself, rather than mixing it with the effects of changing weather, emissions from vehicles and industry, or other factors that also affect air quality.

The satellite observations showed an overall increase in vegetation across East Asia, although the pattern was far from uniform. Several areas of China experienced pronounced greening, while parts of Japan showed localized declines. Such differences matter because the quantity and chemical composition of BVOCs depend not only on how much vegetation is present, but also on the types of plants growing in a region. A larger forested area, for example, may emit a different mixture of reactive compounds than cropland, shrubland, or urban vegetation.

When the updated vegetation information was incorporated into the model, calculated emissions of BVOCs changed significantly. Those changes were then transmitted through the atmosphere’s chemical network, modifying concentrations of ozone and biogenic secondary organic aerosols. The strongest responses appeared in suburban areas, where vegetation was sufficiently abundant to influence emissions and nitrogen oxides were present at levels capable of driving secondary pollutant formation.

The results also reveal why the relationship between greening and air quality is not straightforward. In heavily built-up urban areas, vegetation changes were relatively limited, even though nitrogen oxide concentrations were high. That restricted the overall response to updated plant data. In rural regions, vegetation changes were often more substantial, but nitrogen oxide levels were too low to support the same degree of ozone and aerosol production. Suburban environments occupied the critical middle ground, combining enough vegetation with enough nitrogen oxides to amplify atmospheric reactions.

This interaction reflects a central principle of atmospheric chemistry: pollutant formation depends on combinations of ingredients, not on a single emission source. BVOCs can either contribute strongly to ozone production or have a more limited effect depending on the amount of nitrogen oxides, sunlight, temperature, and other chemical conditions. The same increase in vegetation can therefore produce different air-quality outcomes in different locations. Greening is not automatically beneficial or harmful; its atmospheric consequences depend on the surrounding chemical environment.

“Our results show that updating vegetation information alone can substantially change biogenic emissions, O₃, and biogenic secondary organic aerosols,” says Professor Hyo-Jung Lee of Pusan National University, who led the study with Research Professor Yu-Jin Jo and collaborators including Dr. Younha Kim of the International Institute for Applied Systems Analysis. The researchers argue that regularly refreshed satellite observations should become a standard component of atmospheric chemistry modeling, especially as climate change continues to reshape ecosystems.

The study focused on August 2024, a period when vegetation activity is near its annual peak in much of East Asia. The authors say future research will extend the analysis across additional seasons and longer time periods, allowing scientists to determine whether the observed effects persist during spring, autumn, and winter, when plant activity and atmospheric conditions differ. More accurate vegetation data could ultimately improve operational air-quality forecasts, strengthen pollution-control strategies, and help policymakers anticipate how ecosystem change will interact with emissions from human activities.

Subject of Research: Not applicable

Article Title: Impacts of climate-driven vegetation changes on air quality over East Asia: Modulation of biogenic VOC emissions and secondary pollutants

News Publication Date: 15 June 2026

Web References: https://www.sciencedirect.com/science/article/abs/pii/S0013935126007231

References: Environmental Research. DOI: 10.1016/j.envres.2026.124392

Image Credits: Professor Hyo-Jung Lee and Research Professor Yu-Jin Jo, Pusan National University, Republic of Korea

Keywords: climate change, East Asia, vegetation change, air quality, ozone, biogenic volatile organic compounds, secondary organic aerosols, satellite observations, atmospheric chemistry, nitrogen oxides

The study’s methodology employed a sophisticated artificial intelligence framework that integrated multi-layered omics data including genomics, transcriptomics, proteomics, and epigenomics. By processing and cross-referencing vast datasets from populations exposed to varying levels of PM2.5, the AI model pinpointed NPC1 as a pivotal factor influencing how SARS-CoV-2 interacts with host cells. This multi-omics approach allowed for a nuanced interrogation of the cellular landscape, revealing the complex interplay between environmental pollutants and host genetic factors that dictate susceptibility.

Atmospheric particulate matter with diameters smaller than 2.5 micrometers, commonly referred to as PM2.5, is a notorious pollutant linked to a broad array of respiratory and cardiovascular ailments. Its tiny size enables deep lung penetration and systemic circulation, where it can incite inflammation and immune dysregulation. The team’s findings suggest that PM2.5 exposure modulates NPC1 expression and function within lung epithelial cells, thereby altering the dynamics of SARS-CoV-2 entry and replication. This interconnection provides a molecular explanation for the epidemiological observations of higher COVID-19 morbidity and mortality rates in highly polluted regions.

NPC1 is an intracellular cholesterol transporter traditionally implicated in Niemann-Pick disease, a lysosomal storage disorder. The protein resides primarily in the membranes of late endosomes and lysosomes, organelles integral to intracellular trafficking and pathogen processing. The new research reveals NPC1’s unsuspected role as a facilitator of viral entry and infection. Mechanistically, elevated PM2.5 exposure recalibrates cellular lipid metabolism pathways, augmenting NPC1 activity, which in turn enhances SARS-CoV-2’s ability to hijack endosomal pathways to enter host cells more effectively.

The AI model developed utilized advanced deep learning algorithms, enabling it to sift through the complex non-linear relationships within the multi-omics data. This allowed for the identification of NPC1 not just as an isolated factor, but as part of a broader regulatory network altered by PM2.5 exposure. Through this systems biology lens, researchers could delineate key signaling cascades and transcriptional programs modified by environmental pollution, providing an integrated picture of how external pollutants rewire cellular infrastructure to favor viral infection.

Importantly, the study also explored how modulation of NPC1 expression impacts viral replication post-entry. Using in vitro cell culture models treated with PM2.5 extracts, the researchers demonstrated that cells with upregulated NPC1 exhibited significantly increased viral load, underscoring the protein’s functional relevance beyond mere viral docking. Moreover, pharmacological inhibition of NPC1 resulted in reduced viral replication, invoking the potential for repurposed drugs targeting NPC1 as adjunct therapies for COVID-19, particularly in polluted urban settings.

The environmental aspect of the study underscores the public health implications of chronic PM2.5 exposure. By elucidating the molecular pathways linking pollution to infectious disease susceptibility, the research shifts the narrative from solely focusing on direct viral mitigation strategies to incorporating environmental remediation as an equally vital component. This could catalyze policy reforms aiming to reduce ambient air pollution as a means of curbing pandemic severity and enhancing population resilience against respiratory viruses.

One of the study’s novel contributions is its demonstration of how AI can accelerate discovery in complex biological systems influenced by environmental factors. Traditional methods of dissecting such multifaceted interactions are often time-consuming and limited by the scale of data. Here, AI-driven multi-omics fusion enabled rapid hypothesis generation and testing, illustrating the vast potential for computational approaches in future epidemiological and mechanistic viral pathogenesis research.

Beyond SARS-CoV-2, the mechanistic insights into NPC1’s role within pollutant-exposed cells may have wider implications for understanding host-pathogen interactions in various infectious diseases. Given NPC1’s involvement in cholesterol trafficking—a process critical for many viral life cycles—this protein could serve as a universal nodal point that environmental stressors exploit to exacerbate infectious disease risk, warranting broader investigation across virology.

The researchers also provided a comprehensive analysis of cellular transcriptomic shifts upon PM2.5 exposure, noting upregulation of inflammatory cytokines and dysregulation of interferon signaling pathways. These changes further exacerbate host susceptibility by compromising innate immune defenses and may synergize with NPC1’s facilitation of viral entry. This multilayered immune modulation underscores the complex biological disruption caused by pollution, which extends beyond just mechanical obstruction to active biochemical reprogramming.

In terms of translational applications, the study opens new avenues for developing diagnostic tools that incorporate environmental exposure profiles and NPC1 expression status to predict COVID-19 risk. Such precision medicine approaches could inform targeted interventions and prioritize resource allocation in high-risk communities, embodying a shift toward more holistic pandemic management models that integrate environmental, molecular, and clinical data streams.

Moreover, the findings stimulate a re-examination of existing treatment paradigms. Traditionally, antiviral strategies have focused primarily on viral proteins or host receptors such as ACE2. This study spotlights intracellular trafficking regulators like NPC1 as additional viable targets. Future pharmacological development could focus on small molecules or biologics that modulate NPC1’s activity or expression, potentially serving as adjuncts that reduce viral load and improve clinical outcomes, especially in populations burdened by environmental pollution.

The study also highlighted the spatial heterogeneity of PM2.5 effects on lung tissue, detailing how localized alterations in NPC1 expression can create microenvironments permissive to viral proliferation. This granularity points to the importance of considering tissue-specific responses in both research and clinical intervention design, acknowledging that exposure does not uniformly affect all regions of the respiratory tract.

Harnessing AI’s power, the researchers developed predictive modeling frameworks that anticipate future outbreak severity based on pollution trends and population genetic susceptibility patterns involving NPC1 polymorphisms. These predictive tools could greatly enhance public health preparedness, enabling preemptive measures such as targeted vaccination campaigns or pollution control efforts timed according to predicted risk windows.

The cross-disciplinary approach championed by Feng and colleagues exemplifies the next frontier in infectious disease research, where integration of cutting-edge AI analytics, molecular biology, and environmental health converge to unravel hidden layers of disease vulnerability. This paradigm not only broadens scientific understanding but also empowers policymakers, clinicians, and researchers to craft more effective and equitable health interventions.

In summary, the revelation that NPC1 modulates SARS-CoV-2 susceptibility under PM2.5 exposure is a pivotal advancement, exposing previously unrecognized molecular crosstalk between environmental pollutants and viral infection mechanisms. This knowledge spotlights the urgent need for interdisciplinary strategies to combat pandemics, emphasizing environmental health as a cornerstone of infectious disease prevention and control in our increasingly industrialized and polluted world.

Subject of Research:
Investigating the role of NPC1 protein in modulating susceptibility to SARS-CoV-2 infection under exposure to fine particulate matter (PM2.5) using AI-guided multi-omics analysis.

Article Title:
AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PM2.5 exposure.

Article References:
Feng, G., Dong, Z., Ke, L. et al. AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PM2.5 exposure. Nat Commun (2026). https://doi.org/10.1038/s41467-026-71196-3

Image Credits: AI Generated